scholarly journals Consumption of Curcumin Elevates Fecal Immunoglobulin A, an Index of Intestinal Immune Function, in Rats Fed a High-Fat Diet

2010 ◽  
Vol 56 (1) ◽  
pp. 68-71 ◽  
Author(s):  
Yukako OKAZAKI ◽  
Yunkyung HAN ◽  
Mai KAYAHARA ◽  
Toshiro WATANABE ◽  
Hirofumi ARISHIGE ◽  
...  
2021 ◽  
Vol 22 (3) ◽  
pp. 1165
Author(s):  
Yuta Sakamoto ◽  
Masatoshi Niwa ◽  
Ken Muramatsu ◽  
Satoshi Shimo

Several studies highlighted that obesity and diabetes reduce immune function. However, changes in the distribution of immunoglobins (Igs), including immunoglobulin-A (IgA), that have an important function in mucosal immunity in the intestinal tract, are unclear. This study aimed to investigate the impaired immune functions in the context of a diet-induced obese murine model via the assessment of the Igs in the intestinal villi. We used mice fed a high-fat diet (HFD) from four to 12 or 20 weeks of age. The distributions of IgA, IgM, and IgG1 were observed by immunohistochemistry. Interestingly, we observed that IgA was immunolocalized in many cells of the lamina propria and that immunopositive cells increased in mice aged 12 to 20 weeks. Notably, mice fed HFD showed a reduced number of IgA-immunopositive cells in the intestinal villi compared to those fed standard chow. Of note, the levels of IgM and IgG1 were also reduced in HFD fed mice. These results provide insights into the impaired mucosal immune function arising from diet-induced obesity and type 2 diabetes.


2005 ◽  
Vol 8 (1) ◽  
pp. 13-18 ◽  
Author(s):  
Daekeun Kwon ◽  
Keumhee Hwang ◽  
Youngkyun Kim ◽  
Kwangho Lee ◽  
Hoyoul Kang ◽  
...  

2019 ◽  
Vol 38 (2) ◽  
pp. 55-64 ◽  
Author(s):  
Teresia Aluoch MUHOMAH ◽  
Naoki NISHINO ◽  
Emiko KATSUMATA ◽  
Wu HAOMING ◽  
Takeshi TSURUTA

Molecules ◽  
2019 ◽  
Vol 24 (6) ◽  
pp. 1139 ◽  
Author(s):  
Qihui Luo ◽  
Dongjing Cheng ◽  
Chao Huang ◽  
Yifan Li ◽  
Chengjie Lao ◽  
...  

Background: The damage to intestinal barrier function plays an important role in the development of obesity and associated diseases. Soy isoflavones are effective natural active components for controlling obesity and reducing the level of blood lipid. Here, we explored whether these effects of soy isoflavones were associated with the intestinal barrier function. Methods and Results: The obese rat models were established by high fat diet feeding. Then, those obese rats were supplemented with soy isoflavones at different doses for 4 weeks. Our results showed that obesity induced the expressions of pro-inflammatory cytokines, decreased the anti-inflammatory cytokine (IL-10) expression, elevated intestinal permeability, altered gut microbiota and exacerbated oxidative damages in colon. The administration of soy isoflavones reversed these changes in obese rats, presenting as the improvement of intestinal immune function and permeability, attenuation of oxidative damage, increase in the fraction of beneficial bacteria producing short-chain fatty acids and short-chain fatty acid production, and reduction in harmful bacteria. Furthermore, soy isoflavones blocked the expressions of TLR4 and NF-κB in the colons of the obese rats. Conclusions: Soy isoflavones could improve obesity through the attenuation of intestinal oxidative stress, recovery of immune and mucosal barrier, as well as re-balance of intestinal gut microbiota.


Aquaculture ◽  
2018 ◽  
Vol 496 ◽  
pp. 19-29 ◽  
Author(s):  
Qiang Ma ◽  
Ling-Yu Li ◽  
Jia-Yi Le ◽  
Dong-Liang Lu ◽  
Fang Qiao ◽  
...  

2011 ◽  
Vol 141 (11) ◽  
pp. 1975-1981 ◽  
Author(s):  
Yukako Okazaki ◽  
Hiroyuki Tomotake ◽  
Kazuhisa Tsujimoto ◽  
Masahiro Sasaki ◽  
Norihisa Kato

2020 ◽  
Vol 11 (7) ◽  
pp. 6552-6564
Author(s):  
Yuxin Cheng ◽  
Shuxin Tang ◽  
Yuting Huang ◽  
Fuqiang Liang ◽  
Yajing Fang ◽  
...  

Intestinal secretory immunoglobulin A (sIgA)-improving function of Lactobacillus casei-fermented blueberry pomace (FBP) was investigated in this study.


2018 ◽  
Vol 119 (12) ◽  
pp. 1393-1399 ◽  
Author(s):  
Erin D. Lewis ◽  
Zhihong Ren ◽  
Jason DeFuria ◽  
Martin S. Obin ◽  
Simin N. Meydani ◽  
...  

AbstractBlueberry, rich in antioxidant and anti-inflammatory phytochemicals, has been demonstrated to lower inflammatory status in adipose induced by high-fat diet (HFD) and obesity. The effect of blueberry on systemic immune functions has not been examined. C57BL/6 mice were randomised to one of three diets – low-fat diet (LFD), HFD and HFD plus 4 % (w/w) blueberry (HFD+B) – for 8 or 12 weeks. Ex vivo T-cell mitogens (concanavalin A (Con A); phytohaemagglutinin), T-cell antibody (anti-CD3; anti-CD3/CD28)-stimulated T-cell proliferation and cytokine production were assessed. After 8 weeks, both HFD groups weighed more (>4 g) than the LFD group; after 12 weeks, HFD+B-fed mice weighed more (>6 g) and had 41 % more adipose tissue than HFD-fed mice (P<0·05). After 12 weeks, T-cell proliferation was less in both HFD groups, compared with the LFD group. HFD-associated decrements in T-cell proliferation were partially (10–50 %) prevented by blueberry supplementation. At 12 weeks, splenocytes from HFD mice, but not from HFD+B mice, produced 51 % less IL-4 (CD3/CD28) and 57 % less interferon-γ (Con A) compared with splenocytes from LFD mice (P<0·05). In response to lipopolysaccharide challenge, splenocytes from both HFD groups produced 24–30 % less IL-6 and 27–33 % less TNF-α compared with splenocytes from LFD mice (P<0·05), indicating impaired acute innate immune response. By demonstrating deleterious impacts of HFD feeding on T-cell proliferation and splenocyte immune responses, our results provide insights into how HFD/obesity can disrupt systemic immune function. The protective effects of blueberry suggest that dietary blueberry can buttress T-cell and systemic immune function against HFD-obesity-associated insults.


Sign in / Sign up

Export Citation Format

Share Document